These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 31163035)

  • 1. Tardive dyskinesia among patients using antipsychotic medications in customary clinical care in the United States.
    Loughlin AM; Lin N; Abler V; Carroll B
    PLoS One; 2019; 14(6):e0216044. PubMed ID: 31163035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative Burden of Illness in Veterans With Tardive Dyskinesia and Serious Mental Disorders.
    Caroff SN; Leong SH; Roberts C; Berkowitz RM; Campbell EC
    J Clin Psychopharmacol; 2020; 40(1):38-45. PubMed ID: 31834084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis.
    Carbon M; Hsieh CH; Kane JM; Correll CU
    J Clin Psychiatry; 2017 Mar; 78(3):e264-e278. PubMed ID: 28146614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the risk of tardive dyskinesia in older adults with first-generation and second-generation antipsychotics: a systematic review and meta-analysis.
    O'Brien A
    Int J Geriatr Psychiatry; 2016 Jul; 31(7):683-93. PubMed ID: 26679687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors associated with tardive dyskinesia among Indian patients with schizophrenia.
    Achalia RM; Chaturvedi SK; Desai G; Rao GN; Prakash O
    Asian J Psychiatr; 2014 Jun; 9():31-5. PubMed ID: 24813033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of tardive dyskinesia secondary to antipsychotic medication use among patients with mental disorders.
    McEvoy J; Park T; Schilling T; Terasawa E; Ayyagari R; Carroll B
    Curr Med Res Opin; 2019 Jul; 35(7):1205-1214. PubMed ID: 30638073
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk assessment and prediction of TD incidence in psychiatric patients taking concomitant antipsychotics: a retrospective data analysis.
    Patterson-Lomba O; Ayyagari R; Carroll B
    BMC Neurol; 2019 Jul; 19(1):174. PubMed ID: 31325958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital utilization rates following antipsychotic dose reductions: implications for tardive dyskinesia.
    Caroff SN; Mu F; Ayyagari R; Schilling T; Abler V; Carroll B
    BMC Psychiatry; 2018 Sep; 18(1):306. PubMed ID: 30249218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for the treatment of tardive dyskinesia in schizophrenia patients.
    Witter DP; Holbert RC; Suryadevara U
    Expert Opin Pharmacother; 2017 Jul; 18(10):965-972. PubMed ID: 28443349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.
    Margolese HC; Chouinard G; Kolivakis TT; Beauclair L; Miller R; Annable L
    Can J Psychiatry; 2005 Oct; 50(11):703-14. PubMed ID: 16363464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of Antipsychotic Use: Antipsychotic-Induced Movement Disorders, with a Focus on Tardive Dyskinesia.
    Dilks S; Xavier RM; Kelly C; Johnson J
    Nurs Clin North Am; 2019 Dec; 54(4):595-608. PubMed ID: 31703784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Phenotype of Tardive Dyskinesia in Bipolar Disorder.
    Gardea-Resendez M; Taylor-Desir MJ; Romo-Nava F; Bond D; Vallender EJ; Cuellar-Barboza AB; Prieto ML; Nunez N; Veldic M; Ozerdem A; Singh B; Markota M; Colby CL; Coombes BJ; Biernacka JM; McElroy SL; Frye MA
    J Clin Psychopharmacol; 2022 Mar-Apr 01; 42(2):159-162. PubMed ID: 35230047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder.
    Josiassen RC; Kane JM; Liang GS; Burke J; O'Brien CF
    Psychopharmacol Bull; 2017 Aug; 47(3):61-68. PubMed ID: 28839341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort.
    Misdrahi D; Tessier A; Daubigney A; Meissner WG; Schurhoff F; Boyer L; Godin O; Bulzacka E; Aouizerate B; Andrianarisoa M; Berna F; Capdevielle D; Chereau-Boudet I; D'Amato T; Dubertret C; Dubreucq J; Faget-Agius C; Lançon C; Mallet J; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Fond G;
    J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30695288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, clinical correlates and risk factors associated with Tardive Dyskinesia in Chinese patients with schizophrenia.
    Uludag K; Wang DM; Goodman C; Chen DC; Wang L; Zhang X
    Asian J Psychiatr; 2021 Dec; 66():102877. PubMed ID: 34638091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Antipsychotic Dosage in Patients With Tardive Dyskinesia: A Case-Control Study Using the Claims Database of the Corporate Health Insurance Association.
    Gouda M; Abe M; Watanabe Y; Kato TA
    J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):378-385. PubMed ID: 38829574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Tardive Dyskinesia in an Electronic Medical Record Study at a Large Community Mental Health Treatment Center.
    North CS; McDonald K; Hunter J; Burruss J
    Prim Care Companion CNS Disord; 2022 Jun; 24(4):. PubMed ID: 35768015
    [No Abstract]   [Full Text] [Related]  

  • 20. Tardive dyskinesia in Chinese patients with schizophrenia: Prevalence, clinical correlates and relationship with cognitive impairment.
    Liang Q; Wang D; Zhou H; Chen D; Xiu M; Cui L; Zhang X
    J Psychiatr Res; 2022 Jul; 151():181-187. PubMed ID: 35489178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.